New Key Statistics Module, Z-Score and F-Score
NAS:ABEO Key Ratios
| Market Cap $ M | 171.56 |
| Enterprise Value $ M | 124.74 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.51 |
| Price/Sales | 21.65 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -2.58 |
| Beneish M-Score | 4.39 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 41.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.32 |
| EV-to-EBITDA | -2.47 |
| PEG | -- |
| Shares Outstanding M | 40.85 |
| Net Margin (%) | -1,548.23 |
| Operating Margin % | -1,377.14 |
| Pre-tax Margin (%) | -1,548.23 |
| Quick Ratio | 4.15 |
| Current Ratio | 4.15 |
| ROA % (ttm) | -89.95 |
| ROE % (ttm) | -295.43 |
| ROIC % (ttm) | -356.96 |
| Dividend Yield % | -- |
| Altman Z-Score | -16.23 |
ABEO Number of Guru Trades
ABEO Volume of Guru Trades
Gurus Latest Trades with NAS:ABEO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABEO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Abeona Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ABEO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers